Barclays’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,569
| Closed | -$394K | – | 5545 |
|
|
2024
Q2 | $394K | Sell |
14,569
-22,929
| -61% | -$477K | ﹤0.01% | 3193 |
|
|
2024
Q1 | $687K | Sell |
37,498
-15,263
| -29% | -$242K | ﹤0.01% | 3385 |
|
|
2023
Q4 | $647K | Buy |
52,761
+38,826
| +279% | +$364K | ﹤0.01% | 3719 |
|
|
2023
Q3 | $209K | Sell |
13,935
-649
| -4% | -$13.5K | ﹤0.01% | 3275 |
|
|
2023
Q2 | $474K | Sell |
14,584
-4,417
| -23% | -$161K | ﹤0.01% | 2784 |
|
|
2023
Q1 | $744K | Buy |
19,001
+8,819
| +87% | +$431K | ﹤0.01% | 2965 |
|
|
2022
Q4 | $538K | Buy |
10,182
+8,611
| +548% | +$419K | ﹤0.01% | 3271 |
|
|
2022
Q3 | $71K | Sell |
1,571
-163
| -9% | -$7.01K | ﹤0.01% | 3671 |
|
|
2022
Q2 | $63K | Sell |
1,734
-3,996
| -70% | -$145K | ﹤0.01% | 3955 |
|
|
2022
Q1 | $236K | Sell |
5,730
-35,955
| -86% | -$1.27M | ﹤0.01% | 3324 |
|
|
2021
Q4 | $1.78M | Buy |
41,685
+27,819
| +201% | +$1.39M | ﹤0.01% | 2460 |
|
|
2021
Q3 | $763K | Buy |
13,866
+3,571
| +35% | +$187K | ﹤0.01% | 2943 |
|
|
2021
Q2 | $493K | Sell |
10,295
-17,040
| -62% | -$868K | ﹤0.01% | 3082 |
|
|
2021
Q1 | $1.38M | Sell |
27,335
-13,763
| -33% | -$765K | ﹤0.01% | 2562 |
|
|
2020
Q4 | $2.59M | Buy |
41,098
+28,776
| +234% | +$1.79M | ﹤0.01% | 2038 |
|
|
2020
Q3 | $828K | Sell |
12,322
-5,987
| -33% | -$327K | ﹤0.01% | 2850 |
|
|
2020
Q2 | $767K | Buy |
18,309
+12,968
| +243% | +$498K | ﹤0.01% | 2987 |
|
|
2020
Q1 | $168K | Sell |
5,341
-16,650
| -76% | -$667K | ﹤0.01% | 4442 |
|
|
2019
Q4 | $888K | Buy |
21,991
+16,124
| +275% | +$565K | ﹤0.01% | 3782 |
|
|
2019
Q3 | $191K | Buy |
5,867
+1,380
| +31% | +$55K | ﹤0.01% | 5004 |
|
|
2019
Q2 | $217K | Buy |
+4,487
| New | +$191K | ﹤0.01% | 5032 |
|
Other funds holding SILK
Barclays's SILK Position: Q3 2024 in Review
Barclays sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 14,569 shares — an estimated $394K sold.
Barclays first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $2.59M in Q4 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Barclays reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Barclays sold 14,569 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $394K.
- Barclays first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Barclays's Silk Road Medical, Inc. Common Stock position peaked at $2.59M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.